Company news: J&J's Janssen

Share this article:
An Arkansas judge levied a $1.2 billion fine on Johnson & Johnson's Janssen after a jury there found the pharma giant guilty of downplaying the risks of its antipsychotic Risperdal. The fine is far and away the largest in a statewide case, though judges and juries in South Carolina, Louisiana and Texas have ordered the firm to pay more than three-quarters of a billion dollars in Risperdal cases combined. J&J's Ortho-McNeil and Janssen units are operating under at federal Corporate Integrity Agreement related to Topamax marketing abuses.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions